2023-05-03 19:00:45
- At first it was said that the Vaccina Patria would be ready in December 2021, but the project suffered multiple delays.
- The Conacyt affirms that the cost of this biological will be 88% lower compared to the others that are currently available.
- According to the National Vaccination Strategy, current immunization coverage in Mexico is 84% in all population segments.
The situation regarding the pandemic looks promising due to the considerable drop in infections worldwide. There are even countries like the United States that have already put an end to the health emergency despite the fact that it is an exclusive decision of the World Health Organization (WHO). In the midst of this panorama today it was announced that finally the Vaccina Patria concluded its development and is now ready to be applied.
Total infections registered in the world
According to the data updated to April 28, a total of 764.5 million cases have been registered worldwide. Although in the area where a significant decrease is appreciated, it is in deaths.
For its part, the Ministry of Health (SSa) published that in epidemiological week 17, which corresponds to April 23-29, the country registered a daily average of 890 infections and six deaths due to the SARS-Cov-virus. 2.
With respect to National Vaccination Strategy, coverage is 84 percent in all population segments. By age groups, it reaches 91 percent in people over 18 years of age; 64 percent in adolescents; and 61 percent in girls and boys between the ages of five and 11.
Vaccina Patria, the first Mexican vaccine against Covid-19
However, since the beginning of the pandemic it was announced that Mexico would have its own immunization to deal with this disease. In the first instance it was said that in December 2021 it would be ready and in charge of this project the National Council of Science and Technology (Conacyt) and Avi-Mex Laboratory, SA of CV
Despite the initial promise, there were several delays. While almost a year and a half after the agreed date, the Vaccina Patria was finally completed. In this case, President Andrés Manuel López Obrador announced that the biological is already finished. He added that it successfully passed all the clinical phases and demonstrated proper functioning, although he did not mention its percentage of efficacy.
I am very pleased to report this morning at the president’s conference @lopezobrador_that the vaccine #Patria has successfully completed the clinical phases and the results obtained allow us to communicate that it is safe, immunogenic and effective as a booster vaccine for COVID19 pic.twitter.com/M9kj8DveDo
— María Elena Álvarez-Buylla Roces (@ElenaBuylla) May 3, 2023
Just in January of this year, a call was published requesting the participation of 3,860 volunteers. Based on what was declared, the biological approved phase 3 and therefore managed to advance to the final stage.
He indicated that at the moment the homeland vaccine It is in the process of authorization by the Federal Commission for the Protection against Sanitary Risks (Cofepris).
Based on what is planned, it is a matter of months for it to be endorsed by the corresponding authority. Therefore, between September and December 2023 alone, more than 4 million doses are expected to be produced and all of them will be applied as booster immunization in our country.
Besides, Maria Elena Alvarez-Buyllawho is the head of Conacyt, said that one of the main benefits of having a national vaccine can be seen in the financial area.
According to the official, the total cost of the Vaccina Patria will be 88% lower compared to the other biologicals that are currently applied in the country.
Also read:
From Mexico to the world: Vaccina Patria advances to the final stage of clinical development
Mexican vaccine ‘Patria’ will be ready in December but first it needs volunteers
Vaccina Patria: Conacyt requests volunteers for the final stage and these are the requirements
#Vaccina #Patria #ready #applied #booster